Novel Agent Reduces Bowel Movement Frequency in Carcinoid Syndrome

Novel Agent Reduces Bowel Movement Frequency in Carcinoid Syndrome

5
(209)
Write Review
More
$ 8.50
Add to Cart
In stock
Description

Clinical trial - Ronny Allan - Living with Neuroendocrine Cancer

Cancers, Free Full-Text

JCM, Free Full-Text

Pancreatic neuroendocrine tumours

Frontiers Epigenetic Regulation in Gastroenteropancreatic

Vitamins

Frontiers Increasing Evidence That Irritable Bowel Syndrome and

Life-threatening diarrhea in neuroendocrine tumors: two case

Life-threatening diarrhea in neuroendocrine tumors: two case

Neuroendocrine neoplasms of the lung and gastrointestinal system

Changes in Weight Associated With Telotristat Ethyl in the